AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca Israel was established at the end of 2008 and is based in Kfar Saba, employing over 100 people, specializing in sales, marketing, medical & regulatory affairs. In addition AstraZeneca Israel has a strong presence of scientific research and development with partnerships across the country.

In May 2019 AstraZeneca signed a MOU (memorandum of understanding) with the Israeli innovation authority, committing to invest and support the Israeli healthcare ecosystem. AstraZeneca Israel is part oftheAstraZenecaHealth Innovation Hubs networkalongsidethe US, China, Sweden, and France